11/21
08:38 am
cdtx
Cidara Therapeutics Announces $105 Million Private Placement [Yahoo! Finance]
Medium
Report
Cidara Therapeutics Announces $105 Million Private Placement [Yahoo! Finance]
11/21
08:30 am
cdtx
Cidara Therapeutics Announces $105 Million Private Placement
High
Report
Cidara Therapeutics Announces $105 Million Private Placement
11/19
08:08 am
cdtx
Cidara Therapeutics to Participate in Evercore 7th Annual HealthCONx Conference [Yahoo! Finance]
Medium
Report
Cidara Therapeutics to Participate in Evercore 7th Annual HealthCONx Conference [Yahoo! Finance]
11/19
08:00 am
cdtx
Cidara Therapeutics to Participate in Evercore 7th Annual HealthCONx Conference
Medium
Report
Cidara Therapeutics to Participate in Evercore 7th Annual HealthCONx Conference
11/11
11:15 pm
cdtx
Cidara Therapeutics, Inc. (NASDAQ: CDTX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Low
Report
Cidara Therapeutics, Inc. (NASDAQ: CDTX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
11/11
11:15 pm
cdtx
Cidara Therapeutics, Inc. (NASDAQ: CDTX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Low
Report
Cidara Therapeutics, Inc. (NASDAQ: CDTX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
11/11
08:09 am
cdtx
Cidara Therapeutics, Inc. (NASDAQ: CDTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock.
Low
Report
Cidara Therapeutics, Inc. (NASDAQ: CDTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock.
11/7
06:21 pm
cdtx
Cidara Therapeutics GAAP EPS of -$2.38 beats by $1.87 [Seeking Alpha]
Medium
Report
Cidara Therapeutics GAAP EPS of -$2.38 beats by $1.87 [Seeking Alpha]
11/7
04:15 pm
cdtx
Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
Low
Report
Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
10/31
08:00 am
cdtx
Cidara Therapeutics to Participate in Two Upcoming November Investor Conferences
Low
Report
Cidara Therapeutics to Participate in Two Upcoming November Investor Conferences
10/22
08:32 am
cdtx
Cidara Therapeutics, Inc. (NASDAQ: CDTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock.
Low
Report
Cidara Therapeutics, Inc. (NASDAQ: CDTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock.
10/16
08:00 am
cdtx
Cidara Therapeutics Announces Two Presentations on Drug-Fc Conjugate, CD388, at IDWeek 2024
Medium
Report
Cidara Therapeutics Announces Two Presentations on Drug-Fc Conjugate, CD388, at IDWeek 2024
10/4
04:30 pm
cdtx
Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Low
Report
Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
9/25
08:00 am
cdtx
Cidara Therapeutics Announces Two Presentations on Innovative Drug-Fc Conjugate, CD388, at the 2024 OPTIONS XII for the Control of Influenza Conference
Low
Report
Cidara Therapeutics Announces Two Presentations on Innovative Drug-Fc Conjugate, CD388, at the 2024 OPTIONS XII for the Control of Influenza Conference
9/23
08:00 am
cdtx
Cidara Therapeutics Announces First Subjects Dosed in Phase 2b NAVIGATE Trial Evaluating CD388 for the Prevention of Seasonal Influenza
Medium
Report
Cidara Therapeutics Announces First Subjects Dosed in Phase 2b NAVIGATE Trial Evaluating CD388 for the Prevention of Seasonal Influenza
9/20
04:19 am
cdtx
Biotechs investigate ways to adapt to new clinical trial regulation and economic flux [Yahoo! Finance]
Medium
Report
Biotechs investigate ways to adapt to new clinical trial regulation and economic flux [Yahoo! Finance]
9/19
08:00 am
cdtx
Cidara Therapeutics Strengthens its Scientific Advisory Board with Infectious Disease Experts
Low
Report
Cidara Therapeutics Strengthens its Scientific Advisory Board with Infectious Disease Experts
9/16
08:03 am
cdtx
Cidara Therapeutics, Inc. (NASDAQ: CDTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock.
Low
Report
Cidara Therapeutics, Inc. (NASDAQ: CDTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock.
9/13
11:08 pm
cdtx
Cidara Therapeutics, Inc. (NASDAQ: CDTX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Low
Report
Cidara Therapeutics, Inc. (NASDAQ: CDTX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
9/12
04:05 pm
cdtx
Cidara Therapeutics Restructures Workforce to Focus on Planned Clinical Development of CD388
Medium
Report
Cidara Therapeutics Restructures Workforce to Focus on Planned Clinical Development of CD388
9/5
08:00 am
cdtx
Cidara to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Low
Report
Cidara to Present at the H.C. Wainwright 26th Annual Global Investment Conference